B. DURAK ARAS Et Al. , "EVALUATING THE FREQUENCIES OF EGFR, ALK/EML4, AND ROS1 ALTERATIONS IN LUNG CANCER: A SINGLE-CENTER EXPERIENCE," ESHG 2019 , 2019
DURAK ARAS, B. Et Al. 2019. EVALUATING THE FREQUENCIES OF EGFR, ALK/EML4, AND ROS1 ALTERATIONS IN LUNG CANCER: A SINGLE-CENTER EXPERIENCE. ESHG 2019 .
DURAK ARAS, B., ÇİLİNGİR, O., IŞIK, S., ARSLAN, S., DÜNDAR, E., AK, G., ... TEMENA, M. A.(2019). EVALUATING THE FREQUENCIES OF EGFR, ALK/EML4, AND ROS1 ALTERATIONS IN LUNG CANCER: A SINGLE-CENTER EXPERIENCE . ESHG 2019
DURAK ARAS, BEYHAN Et Al. "EVALUATING THE FREQUENCIES OF EGFR, ALK/EML4, AND ROS1 ALTERATIONS IN LUNG CANCER: A SINGLE-CENTER EXPERIENCE," ESHG 2019, 2019
DURAK ARAS, BEYHAN D. Et Al. "EVALUATING THE FREQUENCIES OF EGFR, ALK/EML4, AND ROS1 ALTERATIONS IN LUNG CANCER: A SINGLE-CENTER EXPERIENCE." ESHG 2019 , 2019
DURAK ARAS, B. Et Al. (2019) . "EVALUATING THE FREQUENCIES OF EGFR, ALK/EML4, AND ROS1 ALTERATIONS IN LUNG CANCER: A SINGLE-CENTER EXPERIENCE." ESHG 2019 .
@conferencepaper{conferencepaper, author={BEYHAN DURAK ARAS Et Al. }, title={EVALUATING THE FREQUENCIES OF EGFR, ALK/EML4, AND ROS1 ALTERATIONS IN LUNG CANCER: A SINGLE-CENTER EXPERIENCE}, congress name={ESHG 2019}, city={}, country={}, year={2019}}